Medicover AB (MCOV B.ST) stock: key figures, P/E, revenue and dividend

Health Care · Sweden · ISIN SE0009778848

Price
23.91 SEK
Market cap
3.61 bn SEK
P/E (2025)
46.59
P/S (2025)
1.52
Dividend yield
0.82 %
Net margin
3.24 %
Return on equity (ROE)
14.45 %
Return on assets (ROA)
3.18 %

Medicover AB financials

Fiscal year20242025
Revenue2.09 bn EUR2.38 bn EUR
Gross profit448.00 m EUR550.00 m EUR
Operating income89.60 m EUR156.70 m EUR
EBIT89.00 m EUR155.00 m EUR
Net income16.00 m EUR77.00 m EUR
Diluted EPS – continuing operations0.11 EUR0.51 EUR

Full history since 2005, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Medicover AB

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public sector clients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.